Current
best practices and rationalistic perspectives in causation-based
prevention, early detection and multidisciplinary treatment
of breast and gastric cancer
|
|
EDITORIAL Time
to Move on From Current Treatment Strategy? ABSTRACT Adenocarcinoma
of the stomach with 800,000 new cases per year worldwide is a
major health problem. Despite its declining incidence it remains
the second leading cause of cancer-related deaths. The decrease
in incidence varies considerably geographically; slow in Asia
and developing countries and rapid in the western world. In the
USA only 21,600 new cases are expected in 2002 [1: www.cancer.org],
but the sharply declining incidence-curve in the last five decades
shows now a trend toward stabilization [1]. By contrast, incidence
in Japan with about 50 new male cases each year per 100,000 population,
vs. only 8.7 in the USA, remains one of the highest in the world. Comments
and questions? Please contact us.
|
|
